Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia. - Test2 - elhamkhani - TriplyDB

Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

http://www.wikidata.org/entity/Q38097339

about

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.Indirect estimation of the comparative treatment effect in pharmacogenomic subgroups.Concepts of 'personalization' in personalized medicine: implications for economic evaluation.Is individualized medicine more cost-effective? A systematic review.Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention.Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes.Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies.

P2860

Q30612258-225AF810-22CC-4547-85C2-6C6AB51500C7 Q34981428-F6666FA9-17A0-4CEC-841E-D95BD98066D1 Q35575935-E15247C8-3344-4490-A36C-E3099ACD2F92 Q38191496-5F5E610C-BC05-4956-AC1A-7F3410A71162 Q38510741-793D0A90-9A8E-4930-914A-8BBCAE6BF1FE Q39262810-57BAE575-9E13-4232-A7C3-AE81E7EAC5BD Q41526681-32EA156D-7E6F-45E0-8BC6-51C4EEEF7A1C Q41764396-0AF042E0-6A36-4F6D-859C-2B6F578233C9 Q44069776-AB64F83D-7638-4640-99B7-48953A87062D

P2860

Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

http://www.wikidata.org/entity/Q38097339

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Review of the cost effectivene ...... ment of hypercholesterolaemia.

@en

type

label

Review of the cost effectivene ...... ment of hypercholesterolaemia.

@en

prefLabel

Review of the cost effectivene ...... ment of hypercholesterolaemia.

@en

P1433

Q38097339-BE5ADCE0-6858-4D57-A3E8-4B4EAF111C19

P1476

Q38097339-D2E8D8A3-1012-4074-B352-D49805D7DD4E

P2093

Q38097339-C61981A9-04A2-4A5E-B9DF-A09F4842EB88

P2860

Q38097339-00404889-28F5-41EB-A746-8B186F990D3B

Q38097339-00774C51-5004-4D5F-A6C7-EC0EC4657830

Q38097339-0773A976-5343-4976-9D4F-BC995EF09E85

Q38097339-17972D3C-E817-4CE4-9B8D-2F355B63BC86

Q38097339-1EE934CD-0F5A-4EE6-871C-835847E701D8

Q38097339-2112D760-0699-4B7B-8F23-918725704701

Q38097339-22B51D9D-A097-4195-9011-A067B33EE6A1

Q38097339-2A2153F8-9BDD-4C1E-8143-93BD2F59DDE8

Q38097339-3317F379-86F8-4C84-81CC-37D014CD6C51

Q38097339-3715ED3C-A214-4382-94E8-6FD26E689E3C

P2888

Q38097339-4F482FCD-1B92-43B3-A4A5-64308B4B3437

P304

Q38097339-91CE11B0-0FF3-4FD1-A4A3-2437935E4325

P31

Q38097339-D616F76E-A1CA-4919-B7F2-2B4CFDDD81B4

P356

Q38097339-1BA5AA4C-2DD7-4B04-AE0D-98EF9119C298

P433

Q38097339-5DCC635A-7DD9-41D4-A518-E362BBBADB51

P478

Q38097339-2B50D7AE-CA16-4A75-8B3E-EC53DBB6B24B

P50

Q38097339-0EAD0263-6ABE-43B0-8AAE-37BD455C84F1

Q38097339-7B92078C-2D45-4CC4-9386-C7FB41C54F47

Q38097339-8FF9011B-C375-4BA4-A802-1CBB407E8904

P577

Q38097339-C63C6117-2E2E-4CB6-899C-5CBC3C6B5363

P698

Q38097339-5B5D765F-7FF8-4400-83B9-4F36B9A64F57

P921

Q38097339-94FCF5D8-792E-4DEF-ABED-C8EFA52C58AD

P356

S40273-013-0045-6

P1433

PharmacoEconomics

P1476

Review of the cost effectivene ...... ment of hypercholesterolaemia.

@en

P2093

Brita Pekarsky

http://www.w3.org/2001/XMLSchema#string

P2860

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening

Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins

Adherence to Medication

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Replication validity of genetic association studies

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies

P2888

s40273-013-0045-6

P304

377-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-013-0045-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Sorich

Michael D Wiese

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23568333

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia